Why Fulgent Genetics Shares Are Trading Higher Today
Fulgent Genetics Inc (NASDAQ:HOTH) agreed to acquire Inform Diagnostics, an independent pathology laboratory based in Irving, Texas, and a portfolio company…
Fulgent Genetics Reports Purchase Of Inform Diagnostics For ~$!70M In Cash On Hand
Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, announced
Fulgent Genetics Announces Strategic Investment In Spatial Genomics; Fulgent Genetics Is Investing Up To $40M To Lead Spatial Genomics’ Series A Financing
Fulgent Genetics, Inc. (NASDAQ:FLGT) ("Fulgent" or the "Company"), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
Here's a roundup of top developments in the biotech space over the last 24 hours.
Stocks In Focus
Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase 2b/3 Study
Earnings Scheduled For February 23, 2022
Companies Reporting Before The Bell
• Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter.
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Corona Doom 3.0: Omicron Surge. Profiting From The Boom In COVID-19 Testing Due To The Omicron Wave
COVID testing in a parking garage in Miami on Tuesday (photo via Jordan Levin).
Good Luck Getting Into A Medical Clinic
Helio Health Announces The Commercial Launch Of HelioLiver
Helio Health (“Helio”) and its commercial partner, Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent”), today announced the commercial launch of HelioLiver™, a multi-analyte blood test that